MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
As you search for breast cancer clinical trials, you’ll likely come across language that says the trial is accepting people with “advanced breast...
Read MoreLiving with Metastatic Breast Cancer During October
October is Breast Cancer Awareness Month. It is often marked in mainstream media and pop culture by pink ribbons and talk of survivors and survival. But for many...
Read MoreDifferent Types of Imaging Scans: How, When, and Why They are Used
Scans are a type of imaging that creates pictures of the inside of the body. Scans are used to diagnose metastatic disease, look for new sites of metastasis,...
Read MoreThe Impact of MBC on Work and Career
Many people diagnosed with stage IV breast cancer continue working throughout treatment. Whether you plan to keep working because you want to (or need to for...
Read MorePD-L1 Biomarker for Immunotherapy
In March 2019, the FDA approved atezolizumab (Tecentriq®), the first PD-1/PD-L1 immune checkpoint inhibitor for metastatic triple-negative breast cancer, based on...
Read MoreDepression & Metastatic Breast Cancer
Depression is common after a metastatic breast cancer diagnosis, whether caused by treatment or emotional stress. Getting support can improve emotional and...
Read MoreLBBC’s Conference on Metastatic Breast Cancer
In June, Living Beyond Breast Cancer (LBBC) held its Annual Conference on Metastatic Breast Cancer. Due to COVID-19 the event was held virtually. You can watch...
Read MoreMetastatic Breast Cancer at a Young Age
Metastatic breast cancer can happen to anyone, including young people. Most research considers a person “young” if they’ve been diagnosed with...
Read MoreHow Participants are Divided into Treatment Groups in Clinical Trials
Randomization is part of clinical trial design that helps researchers prevent accidental bias in the trial results meaning that no outside factors shifted the...
Read MoreSEARCH OUR SITE
for past articles or specific information.